Company Announcements

HORIBA and the Beijing Center for Physical and Chemical Analysis announced in April that they will establish an R&D center to facilitate research on new analysis and measurement methods and equipment.

In May, BioSurplus completed raising the majority of its $1.5 million capital from KI Investment Holdings, which will be used to fund a Boston, Massachusetts, facility.

Agilent is part of a consortium consisting of six research organizations that received a $6 million NIH grant to map and provide quantitative dose-response models for selected pathways for toxicity. The goal is to establish a public data resource to share the results of new testing strategies for assessing human health risks. The project is initially focused on endocrine disruption pathways. Agilent will contribute new strategies for data management and software for data analysis and visualization.

In May, e2V sold its industrial gas-sensing business as well as e2v microsensors, which provides air quality sensors, and e2v Scientific Instruments, which provides X-ray detectors, to newly formed SGX Sensortech, which is backed by Baird Capital Partners Europe, for £14.7 million ($18.8 million). Sales for the businesses totaled £14.8 million ($19.0 million) in fiscal 2012.

GE appointed Sue Siegel, former president of Affymetrix, as corporate vice president and CEO of healthyimagination, a $6 billion effort to provide better health for more people by lowering costs and increasing access.

Eppendorf’s 2011 sales declined 1.3% to €477.8 million ($663.6 million) (see IBO 5/31/12) but increased 4.6% adjusted for currency and portfolio effects. In mid-2011, the company sold a non-core equity holding in North America, resulting in a €18.6 million ($25.8 million) decline in sales. European sales grew 3.6%, sales in Asia/Pacific/Africa rose 9.9%, but North/Latin American sales fell 11.3% (grew 1.8% adjusted for currency and divestment) to make up 40%, 37% and 24% of revenues, respectively.

Spectris named Martha B. Wyrsch, president of Vestas Americas, to its Board in June.

In June, Analytik Jena’s Austrian distributor, LZS-Concept Handels- und Service, changed its name to Analytik Jena Austria.

In June, the International Court of Arbitration ruled in Anton Paar’s favor in a 2008 dispute that arose when Anton Paar terminated its sales contract with DKSH for China, Japan, Singapore and Malaysia. DKSH sued Anton Paar for CHF 5.9 million ($5.5 million) in damages.

The US-China Business Council named Marc N. Casper, president and CEO of Thermo Fisher Scientific, to its Board in June.

PerkinElmer announced that it will establish a Personalized Health Innovation Center of Excellence at its facility in Hopkinton, Massachusetts, for the creation of technologies for scientists developing and commercializing new diagnostic and therapeutic products. The Center will have 350 employees and be fully operational in late 2012.